ADAA is pleased to join our colleagues in promoting transparency and public access to all clinical trial data, positive or negative. The registration and availability of results of clinical trials without bias is critical to assure accurate scientific and clinical advances relevant to the care of patients with anxiety disorders and depression, as well as other medical conditions, and used to guide treatment decisions and optimally advance care. Further, knowledge about the results of clinical trials should be widely available to patients and their family members in their health care decision-making.